Paloma Gastelurrutia
Madrid, MD, Spain
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 37 publications
Implantation of a double allogeneic human engineered tissue graft on damaged heart: insights from the PERISCOPE phase I clinical trial.
Journal: EBioMedicine
Published: September 01, 2023
Evolocumab has no effects on heart failure with reduced ejection fraction injury biomarkers: The EVO-HF trial.
Journal: European journal of heart failure
Published: March 17, 2023
Sacubitril/valsartan affects pulmonary arterial pressure in heart failure with preserved ejection fraction and pulmonary hypertension.
Journal: ESC heart failure
Published: January 18, 2022
Deep Learning Analyses to Delineate the Molecular Remodeling Process after Myocardial Infarction.
Journal: Cells
Published: October 13, 2021
Local administration of porcine immunomodulatory, chemotactic and angiogenic extracellular vesicles using engineered cardiac scaffolds for myocardial infarction.
Journal: Bioactive materials
Published: October 31, 2020
Transitioning From Preclinical Evidence to Advanced Therapy Medicinal Product: A Spanish Experience.
Transitioning From Preclinical Evidence to Advanced Therapy Medicinal Product: A Spanish Experience.
Journal: Frontiers in cardiovascular medicine
Published: September 09, 2020
Impact of Frailty on Mortality and Hospitalization in Chronic Heart Failure: A Systematic Review and Meta-Analysis.
Journal: Journal of the American Heart Association
Published: December 21, 2018
Palliative Care Needs in Heart Failure. A Multicenter Study Using the NECPAL Questionnaire.
Journal: Revista espanola de cardiologia (English ed.)
Published: December 05, 2018
Comorbidities, Fragility, and Quality of Life in Heart Failure Patients With Midrange Ejection Fraction.
Journal: Mayo Clinic proceedings. Innovations, quality & outcomes
Published: September 19, 2018
Last Updated: 09/26/2026